Coronary sinus reducer improves symptoms in patients with refractory angina: ORBITA-COSMIC trial Medha Baranwal11 April 2024 10:00 AM ISTUK: A coronary sinus reducer (CSR) implant showed a symptom alleviation benefit for people with stable coronary artery disease and refractory angina,...
Bexagliflozin found as effective as dapagliflozin for glycemic control in diabetes: Study Medha Baranwal11 April 2024 9:30 AM ISTChina: A 24-week, phase 3 trial has shed light on the safety and efficacy of bexagliflozin versus dapagliflozin as an adjunct to metformin in Chinese...
Lowering cholesterol intake alone may not be enough to prevent CKD, study finds Dr Kartikeya Kohli11 April 2024 7:00 AM ISTSouth Korea: Findings from two Korean cohort studies revealed that simply lowering cholesterol intake may not be sufficient to prevent chronic kidney...
Beta-blocker use after MI and preserved ejection fraction offers no benefit: REDUCE-AMI trial Medha Baranwal10 April 2024 9:30 PM ISTSweden: Findings from the REDUCE-AMI published in The New England Journal of Medicine have shown no benefit of beta-blockers in revascularized...
Pioglitazone add-on therapy in patients with type 2 diabetes effective and safe option for better glycemic control: Study Medha Baranwal10 April 2024 10:00 AM ISTSouth Korea: Adjunctive pioglitazone therapy in type 2 diabetes mellitus (T2DM) inadequately controlled with dapagliflozin and metformin yielded...
MR Study sheds light on anti-inflammatory effects of SGLT-2 inhibitors and their beneficial impact in reducing HF risk Medha Baranwal10 April 2024 10:00 AM ISTChina: A two-sample Mendelian randomization (MR) study provides genetic evidence supporting the anti-inflammatory effects of sodium-glucose...
Adjuvant HBOT is beneficial in treating patients with pyoderma gangrenosum: Study Medha Baranwal10 April 2024 9:00 AM ISTBrazil: A recent study has revealed that adjuvant hyperbaric oxygen therapy (HBOT) may provide some benefits in treating pyoderma gangrenosum...
Liver transplantation: Normothermic regional perfusion tied to better DCD liver allograft outcome, study reveals Medha Baranwal10 April 2024 8:00 AM ISTUSA: A recent study published in JAMA Surgery reports US liver transplant outcomes after normothermic regional perfusion (NRP) versus standard super...
MRI imaging in prostate cancer screening reduces number of unnecessary prostate biopsies: JAMA Medha Baranwal10 April 2024 8:00 AM ISTAustria: Findings from a recent meta-analysis published in JAMA Oncology support the integration of prostate magnetic resonance imaging (MRI) in...
Plasma Aldosterone levels may not predict ICU mortality in patients treated for COVID-19: Study Medha Baranwal9 April 2024 10:30 PM ISTPoland: Plasma aldosterone levels do not predict 28-day mortality in patients treated for COVID-19 in the ICU, a recent study published in Scientific...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
Tirzepatide offers superior glycemic control compared with insulin, irrespective of baseline levels: Study Medha Baranwal8 April 2024 10:00 AM ISTUSA: The post hoc analyses of the SURPASS-3 and SURPASS-4 trials revealed superior glycemic control with tirzepatide compared with insulin in patients...
